MMIRF
Price
$0.02
Change
-$0.03 (-60.00%)
Updated
Nov 17 closing price
Capitalization
35.16M
Intraday BUY SELL Signals
OTLC
Price
$0.09
Change
-$0.00 (-0.00%)
Updated
Dec 3 closing price
Capitalization
40.67M
Intraday BUY SELL Signals
Interact to see
Advertisement

MMIRF vs OTLC

Header iconMMIRF vs OTLC Comparison
Open Charts MMIRF vs OTLCBanner chart's image
Medmira
Price$0.02
Change-$0.03 (-60.00%)
Volume$500
Capitalization35.16M
Oncotelic Therapeutics
Price$0.09
Change-$0.00 (-0.00%)
Volume$247.53K
Capitalization40.67M
MMIRF vs OTLC Comparison Chart in %
MMIRF
Daily Signal:
Gain/Loss:
OTLC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MMIRF vs. OTLC commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MMIRF is a StrongBuy and OTLC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (MMIRF: $0.02 vs. OTLC: $0.09)
Brand notoriety: MMIRF and OTLC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MMIRF: 2% vs. OTLC: 76%
Market capitalization -- MMIRF: $35.16M vs. OTLC: $40.67M
MMIRF [@Biotechnology] is valued at $35.16M. OTLC’s [@Biotechnology] market capitalization is $40.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MMIRF’s FA Score shows that 1 FA rating(s) are green whileOTLC’s FA Score has 0 green FA rating(s).

  • MMIRF’s FA Score: 1 green, 4 red.
  • OTLC’s FA Score: 0 green, 5 red.
According to our system of comparison, OTLC is a better buy in the long-term than MMIRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MMIRF’s TA Score shows that 5 TA indicator(s) are bullish while OTLC’s TA Score has 4 bullish TA indicator(s).

  • MMIRF’s TA Score: 5 bullish, 0 bearish.
  • OTLC’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MMIRF is a better buy in the short-term than OTLC.

Price Growth

MMIRF (@Biotechnology) experienced а 0.00% price change this week, while OTLC (@Biotechnology) price change was -5.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.75%. For the same industry, the average monthly price growth was +5.41%, and the average quarterly price growth was +55.63%.

Industries' Descriptions

@Biotechnology (+0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OTLC($40.7M) has a higher market cap than MMIRF($35.2M). OTLC YTD gains are higher at: 162.500 vs. MMIRF (68.702). MMIRF (-3.24M) and OTLC (-3.36M) have comparable annual earnings (EBITDA) . OTLC has more cash in the bank: 88K vs. MMIRF (18.3K). MMIRF has less debt than OTLC: MMIRF (10.2M) vs OTLC (13.5M). MMIRF has higher revenues than OTLC: MMIRF (254K) vs OTLC (0).
MMIRFOTLCMMIRF / OTLC
Capitalization35.2M40.7M86%
EBITDA-3.24M-3.36M96%
Gain YTD68.702162.50042%
P/E RatioN/AN/A-
Revenue254K0-
Total Cash18.3K88K21%
Total Debt10.2M13.5M76%
FUNDAMENTALS RATINGS
MMIRF vs OTLC: Fundamental Ratings
MMIRF
OTLC
OUTLOOK RATING
1..100
2976
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
6636
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
6585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MMIRF's Valuation (5) in the null industry is somewhat better than the same rating for OTLC (50). This means that MMIRF’s stock grew somewhat faster than OTLC’s over the last 12 months.

MMIRF's Profit vs Risk Rating (100) in the null industry is in the same range as OTLC (100). This means that MMIRF’s stock grew similarly to OTLC’s over the last 12 months.

OTLC's SMR Rating (96) in the null industry is in the same range as MMIRF (100). This means that OTLC’s stock grew similarly to MMIRF’s over the last 12 months.

OTLC's Price Growth Rating (36) in the null industry is in the same range as MMIRF (66). This means that OTLC’s stock grew similarly to MMIRF’s over the last 12 months.

OTLC's P/E Growth Rating (93) in the null industry is in the same range as MMIRF (100). This means that OTLC’s stock grew similarly to MMIRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MMIRFOTLC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
42%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
53%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MMIRF
Daily Signal:
Gain/Loss:
OTLC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MYNDF0.020.01
+52.20%
MYND Life Sciences Inc.
MCOIF6.55N/A
N/A
MultiChoice Group Limited
SARDY15.75N/A
N/A
Sanford Ltd.
BMKDF0.35N/A
N/A
Biomark Diagnostics Inc.
JBARF69.02-0.37
-0.53%
Julius Baer Group Ltd.

MMIRF and

Correlation & Price change

A.I.dvisor tells us that MMIRF and NWPHF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MMIRF and NWPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMIRF
1D Price
Change %
MMIRF100%
N/A
NWPHF - MMIRF
30%
Poorly correlated
N/A
TECX - MMIRF
29%
Poorly correlated
+6.31%
AZTR - MMIRF
24%
Poorly correlated
+6.10%
SRPT - MMIRF
22%
Poorly correlated
+6.69%
SLS - MMIRF
21%
Poorly correlated
+10.79%
More

OTLC and

Correlation & Price change

A.I.dvisor tells us that OTLC and TENX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLC and TENX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLC
1D Price
Change %
OTLC100%
-0.03%
TENX - OTLC
23%
Poorly correlated
+2.00%
MNKD - OTLC
22%
Poorly correlated
N/A
IMTX - OTLC
21%
Poorly correlated
+4.55%
MMIRF - OTLC
15%
Poorly correlated
N/A
IPHYF - OTLC
4%
Poorly correlated
N/A
More